Methylphenidate augmentation of serotonin selective reuptake inhibitors: A case series

Journal of Clinical Psychiatry

Volumn 57, Issue 2, 1996, Pages 72-76

  Stoll, Andrew L ^a,c   Pillay, Srinivasan S ^b,c   Diamond, Lisa ^a   Workum, Susan B ^a,c   Cole, Jonathan O ^b,c  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b MCLEAN HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; CLONAZEPAM; DESIPRAMINE; FLUOXETINE; IMIPRAMINE; METHYLPHENIDATE; NORTRIPTYLINE; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRAZODONE;

ADULT; AGED; ANXIETY NEUROSIS; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DEPRESSION; FEMALE; HUMAN; INSOMNIA; MALE; MINIMAL BRAIN DYSFUNCTION; PRIORITY JOURNAL; REMISSION; SEXUAL DYSFUNCTION;

ADULT; AGED; DEPRESSIVE DISORDER; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FEMALE; FLUOXETINE; HUMANS; MALE; METHYLPHENIDATE; PAROXETINE; SEROTONIN UPTAKE INHIBITORS; TREATMENT OUTCOME;

EID: 0030022134     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Schatzberg AF, Cole JO. Manual of Clinical Psychopharmacology. Washington, DC: American Psychiatric Press; 1991:247-259, 263-277
2. Warneke L. Psychostimulants in psychiatry. Can J Psychiatry 1990;35: 3-10
3. Rosenberg PB, Ahmed I, Hurwitz S. Methylphenidate in depressed medically ill patients. J Clin Psychiatry 1991;52:263-267
4. Joffe RT, Singer W, Levitt AJ, et al. A placebo-controlled comparison of lithium and triiodothyronine augmentation of tricyclic antidepressants in unipolar refractory depression. Arch Gen Psychiatry 1993; 50:387-393
5. Thase ME, Kupfer DJ, Jarrett DB. Treatment of imipramine-resistant recurrent depression, I: an open clinical trial of adjunctive L-triiodothyronine. J Clin Psychiatry 1989;50:385-388
6. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Third Edition, Revised. Washington, DC: American Psychiatric Association; 1987
7. Ward MF, Wender PH, Reimherr FW. The Wender Utah Rating Scale: an aid in the retrospective diagnosis of childhood attention deficit hyperactivity disorder. Am J Psychiatry 1993;150:885-890
8. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Washington, DC: American Psychiatric Association; 1994
9. Kocsis JH, Frances AJ, Voss C, et al. Imipramine treatment for chronic depression. Arch Gen Psychiatry 1988;45:253-257
10. Metz A, Shader RI. Combination of fluoxetine with pemoline in the treatment of major depressive disorder. Int Clin Psychopharmacol 1991;6: 93-96
11. Lazarus LW, Winemiller DR, Lingam VR, et al. Efficacy and side effects of methylphenidate for poststroke depression. J Clin Psychiatry 1992;53: 447-449
12. Masand P, Pickett P, Murray GB. Psychostimulants for secondary depression in medical illness. Psychosomatics 1991;32:203-208
13. Pickett P, Masand P, Murray GB. Psychostimulant treatment of geriatric depressive disorders secondary to medical illness. J Geriatr Psychiatry Neurol 1990;3:146-151
14. Fawcett J, Kravitz HM, Zajecka JM, et al. CNS stimulant potentiation of monoamine oxidase inhibitors in treatment-refractory depression. J Clin Psychopharmacol 1991;11:127-132
15. Gurian B, Rosowsky E. Low-dose methylphenidate in the very old. J Geriatr Psychiatry Neurol 1990;3:152-154
16. Ricaurte GA, Fuller RW, Perry KW, et al. Fluoxetine increases long lasting neostriatal dopamine depletion after administration of d-methamphetamine and d-amphetamine. Neuropharmacology 1983; 22:1165-1169
17. Schmidt CJ, Gibb JW. Role of the serotonin uptake carrier in the neurochemical response to methamphetamine. Neurochem Res 1984;10: 637-648
18. Trulson ME, Trulson V. Reduction in brain serotonin synthesis rate following chronic methamphetamine administration in rats. Eur J Pharmacol 1982;83:97-100
19. Yu DSL, Smith FL, Smith DG. Fluoxetine-induced attenuation of amphetamine self-administration in rats. Life Sci 1986;39:1383-1388
20. Brod TM. Fluoxetine and extrapyramidal side effects [letter]. Am J Psychiatry 1989;146:1353
21. Steur ENHJ. Increase of parkinsonism disability after fluoxetine medication. Neurology 1993;43:211-213
22. Wiener J, Kennedy S. Akinesia and mutism following a methylphenidate challenge test. J Clin Psychopharmacol 1985;5:231-233
23. Joyce PR. Mood response to methylphenidate in depressed patients on zimelidine [letter]. J Clin Psychopharmacol 1986;6:317-318
24. Cohen AJ. Treatment of anergic depression in Hashimoto's thyroiditis with fluoxetine and d-amphetamine. Depression 1993;1: 110-114